Schilkrut R, Duran E, Haverbeck C, Katz I, Vidal P
Arzneimittelforschung. 1978;28(9):1494-5.
65 chronic-schizophrenic outpatients were treated with fluphenazinedecanoate for 24 months. Hallucinations and delusions remitted between week 24 and 36, formal disturbances of thinking occurred in 50% of the patients up to the 24th week, mood disorders and disorders and schizophrenic changes in personality could only gradually be controlled. In the first 3 months of treatment the incidence and intensity of rigor grew up to the critical point after 24 weeks of treatment; by the 60th week of treatment it had completely vanished. Akathisia reached its peak after the first and the 36th week and two different populations could be distinguished. 8% of the patients showed dyskinetic reactions up to the 12th week; 20% of the patients showed hyper- and dyskinesia after 72 weeks of treatment. 30 to 40% of the patients required anticholinergics between the 12th and 48th weeks; after the 84th week this medication was no longer necessary.
65名慢性精神分裂症门诊患者接受了癸酸氟奋乃静治疗,为期24个月。幻觉和妄想在第24周和第36周之间有所缓解,高达50%的患者在第24周前出现思维形式障碍,情绪障碍以及人格方面的精神分裂症变化只能逐渐得到控制。在治疗的前3个月,僵直的发生率和严重程度逐渐上升,在治疗24周后达到临界点;到治疗第60周时,僵直已完全消失。静坐不能在第1周和第36周后达到高峰,且可区分出两类不同的人群。8%的患者在第12周前出现运动障碍反应;20%的患者在治疗72周后出现运动亢进和运动障碍。30%至40%的患者在第12周和第48周之间需要使用抗胆碱能药物;第84周后不再需要这种药物。